Building a Compliant Exhibit Program for Every Phase of a Pharmaceutical Launch

 The Challenge

Traditional custom exhibits felt too rigid for Avenira Therapeutics and the realities of a pharmaceutical launch path. A fully owned exhibit would require significant upfront commitment before the final brand message, claims, safety language, and approval status were settled.

The stakes were high because medical congresses continue to be a meaningful channel for healthcare professional engagement. A Doximity poll of 3,629 clinicians found that 42% regularly attend their specialty’s annual conference, which means launch teams are often using these moments to reach an audience actively investing time in education, peer learning, and product discovery.

Avenira’s internal teams were managing several moving parts:

• Disease-awareness education before product approval
• Branded content planning once approval became more likely
• PRC review cycles across booth graphics, digital content, literature, and schematics
• Potential late-stage revisions to messaging, safety information, and booth components
• A need to scale quickly once launch approval arrived

Avenira’s launch path was still uncertain. Industry research from BIO, Informa Pharma Intelligence, and QLS Advisors found that the overall likelihood of approval from Phase I was 7.9% for clinical development programs studied between 2011 and 2020. That reality made it risky to overcommit to a permanent exhibit strategy too early.

The team needed to build visibility before launch without creating a booth program that would become obsolete if approval timing, claims, safety language, or brand strategy changed.

 The Exhibit Strategy

The exhibit strategy was designed around the way healthcare launches actually unfold: in stages.

Freeman’s 2024 Attendee Intent and Behavior research found that 92% of respondents expected to attend more in-person events in 2024 than in 2023, and 87% said discovering new products, solutions, and partners was a top factor influencing attendance. For Avenira, that meant congress presence mattered before, during, and after launch, but the message had to match the product’s regulatory status at each step.

Rather than build four separate booths, Avenira used one adaptable custom-rental exhibit platform that could evolve across four phases: unbranded awareness, approval readiness, pre-launch preparation, and branded launch education.

The core architecture remained consistent, while the most review-sensitive elements — graphics, messaging, digital content, literature placement, and safety information — could change as the product moved closer to launch.

 Phase 1: Awareness — Unbranded Disease Education  

Before approval, the exhibit focused on unbranded disease-state education. The environment was designed to support meaningful healthcare professional engagement without presenting product claims or branded promotional messaging.

The booth featured neutral, condition-focused graphics, educational messaging, and open conversation areas. There were no product names, branded claims, or launch language. The goal was to create a credible educational presence while the therapy was still progressing through development.

The structure was also built with future adaptability in mind, so key graphic areas, digital content zones, and meeting spaces could later transition into branded use.

 Phase 2: On Our Way to Approval — Modular Pre-Launch Readiness

As the product moved closer to approval, Avenira needed a booth plan that could support internal review without overcommitting to final messaging too early.

The same rental architecture was reused, but select areas were reconfigured to prepare for future branded content. Digital screens, graphic panels, and literature zones were mapped as modular content areas that could be reviewed, revised, or replaced without rebuilding the booth.

This phase allowed Avenira’s internal teams to plan how the booth would eventually support branded education while keeping the public-facing experience appropriate for the product’s current status.

Phase 3: Last Step Before Launch — Review-Ready Launch Shell

In the final pre-launch phase, Avenira used the custom-rental structure as a review-ready launch shell.

The architecture, traffic flow, demo areas, literature placement, and digital zones were planned around the anticipated branded experience. However, content remained flexible so PRC, legal, medical, and regulatory feedback could still be incorporated before final production.

This was where the custom-rental model became especially valuable. Avenira could prepare the booth footprint, attendee journey, and content hierarchy ahead of launch while avoiding the risk of locking in final graphics too early.

Phase 4: Launch — Branded Product Education

At launch, the same exhibit platform transitioned into a branded product education environment.

The product name, approved messaging, safety information, literature, and digital content could now be incorporated into the booth. The flexible rental structure allowed Avenira to replace unbranded graphics with branded panels, update digital content, add launch-specific messaging, and support healthcare professional conversations in a polished, compliant space.

The result was a booth experience that felt intentionally designed for launch, not retrofitted at the last minute.

Why the Custom-Rental Access Model Made Sense 

For Avenira, the custom-rental model offered the right balance of control and flexibility.

The team avoided overbuilding before approval, reduced the need for late-stage structural changes, and created a clear path from unbranded awareness to branded launch education.

Instead of committing to a static owned asset, Avenira had access to a premium exhibit platform that could evolve as regulatory status, messaging, and approved materials changed.

This mattered because pharmaceutical launches rarely move in a straight line. Review cycles, label updates, approval timing, and conference deadlines can all affect what a team is allowed to say and show.

By using a custom-rental exhibit strategy, Avenira could plan ahead while staying adaptable.

The Strategic Value

The value of the custom-rental model was not that Avenira changed everything at every phase. It was that they did not have to.

The same adaptable exhibit system could support multiple regulatory and commercial moments. Avenira kept the core footprint, structure, meeting space, storage, and traffic flow consistent while changing the elements most likely to be affected by approval timing and review: graphics, messaging, digital content, literature, and safety information.

That flexibility reduced waste, protected the team from premature ownership decisions, and gave Avenira a practical way to show up at important medical meetings before, during, and after launch.

For a pharmaceutical brand navigating uncertainty, the custom-rental model was not simply a budget-conscious choice. It was the most logical operational model for a launch environment where the booth needed to evolve as quickly and carefully as the brand itself.